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BACKGROUND: Pleomorphic adenomas are benign salivary gland tumors, which predominantly affect 
the superficial lobe of the parotid gland. The “pleomorphic” nature of the tumor can be explained on the 
basis of its epithelial and connective tissue origin. The tumor has a female predilection between 30-50 
years of age. Slowly progressing asymptomatic swelling is the usual presentation of the tumor. Surgical 
excision of the tumor mass forms the mainstay of treatment, with utmost care taken to preserve the facial 
nerve.  
CASE DETAILS: This case report aims to throw light on an interesting case of pleomorphic adenoma of 
the parotid gland in a 50 years old female patient. The patient presented with a slowly progressing 
asymptomatic swelling on the left side of the face. There is also a special emphasis to a  detailed review of 
literature. 
CONCLUSION: Salivary gland neoplasms can occur at any site where salivary tissue is present.  
Pleomorphic adenoma is the commonest salivary gland tumor characterized by diverse 
histomorphological features. Early diagnosis and treatment plan entails thorough history taking, clinical 
examination, coupled with radiographic and histopathological findings.  






Pleomorphic adenoma (PA), also known as benign 
mixed tumor, is the most common salivary tumor, 
constituting up to two-thirds of all salivary gland 
neoplasms (1). Mostly, PA is located in the parotid 
glands (85%), minor salivary glands (10%), and 
the submandibular glands (5%) (2).  In the 
majority of cases, tumors originate in the 
superficial lobe. However, occasional cases may 
involve the deep lobe of the parotid gland (3) and 
the parapharyngeal space. Minor salivary gland 
tumors are frequently encountered on the palate, 
followed by the lip, cheek, tongue and floor of the 
mouth (4). PA usually manifest as a slow 
progressing asymptomatic, parotid gland swelling 
without facial nerve involvement (5). They are 
best treated by a wide local excision with good 
safety margins and follow-up for at least 3-4 years 
(6). 
A 50 years old female patient reported to the 
Outpatient Department with a chief complaint of 
slow growing, painless swelling on the left side of 
face since 5 years. The swelling was initially small 
in size and had progressively increased with time 
to attain the present size. Past medical and surgical 
history was noncontributory. Extra-oral clinical 
examination revealed a marked facial asymmetry. 
A well-defined, ovoid, multilobular swelling, 8 x 
10 cm in diameter was seen on the left side of the 
face. The swelling had a superioinferior extent 
from left zygomatic arch to about 1 cm below the 
lower border of mandible and anteroposterior 
extent from mid body region to the posterior 
border of mandible. The left ear lobule was 
slightly everted.  Loss of wrinkling of the skin and 
engorged veins was also seen (Figure 1). 
The swelling was firm in consistency, non-
tender and warm on palpation. It was fixed to the 
underlying structures and the overlying skin. 
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Facial and eye movements were normal on 
examination. Intraoral clinical examination was 
unremarkable. A provisional diagnosis of benign 
tumor of the left parotid gland was taken into 
consideration. Pleomorphic adenoma, Warthin’s 
tumor and neuroma of the facial nerve (nerve 
sheath tumor) were considered as the most 
probable differential diagnosis. Warthin’s tumor is 
usually seen in elderly males with a history of 
smoking, does not cause eversion of the ear lobe, 
located in the lower portion of the parotid (near 
angle of mandible), and 10-15% cases show 
bilateral involvement. Benign tumor of nerve 
sheath origin in the parotid gland poses difficulty 
in preoperative diagnosis because of the low 
frequency of occurrence (0.2% to 1.5%).  Also, 
preoperative diagnosis of a parotid tumor as 
neuroma seems challenging without 
accompanying facial nerve dysfunction. 
Panoramic radiographic examination did not 
reveal any abnormality. Magnetic resonance 
imaging (MRI) revealed a large (6.1 x 2.3x 
4.9cm), well-defined, lobulated, heterogeneous 
lesion involving the left upper gingiva-buccal 
sulcus, left retromolar region and bilateral 
pterygoid muscles posteriorly. The lesion 
extended superiorly to the infratemporal fossa 
with infiltration of the infratemporal fat and 
caused bowing of the posterolateral wall of left 
maxillary sinus and laterally abutted the masseter 
muscle. Lesion on T1 weighted MR image 
appeared hypointense and appeared hyperintense 




Fig 1: . (A) Frontal view and (B) Lateral view of 
the face showing left sided facial swelling. 
 
Ultrasonography of the left parotid gland showed 
a hypoechoic area. Fine needle aspiration cytology 
(FNAC) was performed under local anesthesia and 
showed admixed epithelial, myoepithetial and 
mesenchymal tissue elements.   
 
 
Fig 2: (A) Axial MRI - T1 weighted image 
showing a hypo intense lesion. (B) Axial MRI - 
T2 weighted image showing a hyper intense 
lesion. 
 
After obtaining the informed consent of the 
patient, excision of the superior lobe of the left 
parotid gland along with the tumor mass was 
made. A modified Blair incision was given to the 
left preauricular region; platysma muscle and 
superficial musculoaponeurotic layer were 
dissected. The peripheral nerve branches were 
identified and preserved following a retrograde 
approach. Nerves were separated from the 
underlying parotid gland. The tumor was resected 
after separation from the facial nerve and the 




Fig 3: (A) Blunt dissection with the exposed tumor 
mass. (B) Intraoperative procedure showing the 
separation of tumor mass from the nerve bundles. 
 
The excised tumor mass was 8cms x 10cms x 
12cms in dimension. The weight of the excised 
mass was 1.8 kilograms (Figure 4). 
Histopathology revealed a well capsulated, highly 
cellular mass with interspersed epithelial cells and 
myoepithelial cells containing eosinophillic 




cytoplasm. Presence of mucoid material between 
the tumor cells imparted a myxomatous 
background. Chondroid and ductal areas along 
with fat and osteoid were also seen (Figure 5). 
Pleomorphic adenoma, myoepithelioma and 
adenoid cystic carcinoma were considered as the 
probable histologic differential diagnosis. The 
presence of chondromyxoid foci along with 
glanduloductal differentiation excluded the 
histological diagnosis of myoepithelioma.  Lack of 
infiltrative growth pattern and perineural invasion 
ruled out adenoid cystic carcinoma. The 
characteristic features of chondromyxoid foci and 
glanduloductal differentiation confirmed the 
diagnosis of pleomorphic adenoma of the left 




Fig 4: (A) Gross specimen of the resected tumor 




Fig 5: (A) Photomicrograph showing epithelial 
cells in sheets and cords with chondro myxoid 
stroma. (10X) (B) Photomicrograph revealing the 
characteristic features of a pleomorphic adenoma 
includes islands and strands of epithelium in a 
myxoid stroma. (40X) 
 
The patient was periodically followed up for 3 
years and no recurrences or complications were 




Fig 6: (A) Post- operative  facial view. (B) Lateral 
view showing no recurrence of lesion after follow-




World Health Organization (1972) defined PA as 
a well-defined tumor characterized by its 
pleomorphic or mixed appearance. There is 
intermixing of the clearly recognizable epithelial 
component with mucoid, myxoid and chondroid 
component (7). Although the lesion presents 
several histological features due to the different 
compounds with a myxoid or chondroid matrix, it 
is generally considered to be a benign neoplasm 
(8,9).  
The exact etiology is obscure although the 
incidence increases from 15-20 years after 
exposure to radiation. Few studies have suggested 
an association of the tumor with simian virus 40 
(SV 40) (10).   
Pleomorphic adenomas are generally 
discovered during routine physical examination, as 
an asymptomatic mass. PA has a glandular origin 
in the head and neck region and usually manifests 
as a mobile, slow progressing, asymptomatic firm 
swelling that does not cause ulceration of the 
overlying mucosa (11). The majority of these 
tumors measure 2-6 cm in size when excised (12). 
However, large tumor may be seen as a single, 
irregular nodular mass stretching the overlying 
skin or mucosa (13). The tumor may weigh from 
several grams to more than 8 kilograms (14). 
Parotid gland PA is usually seen below the lobule 
of the ear and overlying the angle of the mandible. 
Facial nerve weakness is an infrequent sign in 
parotid tumors although large neglected tumors 
may present with facial nerve weakness (15, 16).  
Oral retrotonsillar mass/ parapharyngeal space 





tumor may be a presenting sign in cases of deep 
lobe involvement (17).
 
Based on clinico-pathological and immune-
histochemical features of 60 cases of PA in Brazil,  
Alves et al. Reported that the tumor occurred 




 decades of life, 
and 37/60 (62%) of the affected patients were 
women (18).
 
Our patient was a 50 years old female who 
presented with a slowly enlarging, multilobular, 
asymptomatic swelling on the left side of the face 
since 5 years. The swelling caused stretching of 
the overlying skin with visible engorged veins and 
slight deflection of the left ear lobule. The ocular 
and facial movements were normal, suggestive of 
intact facial nerve functions. Grossly, the excised 
tumor mass measured 8 x 10 x 12 cm in diameter 
and weighed 1.8kgs. The features in the present 
case were consistent with the previously published 
literature. 
Imaging modalities such as computed 
tomography (CT) and Magnetic Resonance 
Imaging (MRI) are essential aids in diagnosis. 
MRI is favored on the basis of better soft tissue 
delineation, detailed tumor margin description and 
the tumor relationship with the surrounding 
structures (5). 
MRI findings in the present case were 
suggestive of a large well-defined, heterogeneous 
lesion, which appeared hypointense on T1 
weighted MR image and hyperintense on T2 
weighted MR images. Ultrasound imaging helps 
to differentiate cystic lesions from solid parotid 
masses, and is also used for assessment of intra-
capsular versus extra-capsular tumors. PA’s have 
been identified by ultrasound based on their 
distinct margins and polycyclic shape (19).  
Ultrasonographic findings of the present case 
showed a hypoechoic area in the left parotid 
gland. FNAC is a reliable procedure that can guide 
the surgeon to choose the right surgical approach 
(20, 21). The procedure is usually performed 
following diagnostic imaging to rule out a 
vascular lesion although it is not the first choice 
diagnostic tool (22). 
The present case showed a combined pattern 
of epithelial, myoepithetial and mesenchymal 
components on FNAC. The histopathology 
presents varied morphological patterns, showing 
epithelial and myoepithelial cells with interspersed 
areas of mesenchymal differentiation. Epithelial 
cells typically form duct-like structures associated 
with non-ductal cells presenting varying shapes 
and forms. Myxoid, cartilaginous, hyaline, or 
osseous differentiation is appreciated in the 
stromal component. The stroma is presented as a 
mixture of gland-like epithelium and 
mesenchyma-like tissue in varying proportions 
(13). 
As pleomorphic adenoma exhibits a varied 
histopathologic presentation, it may be confused 
histopathologically withmyoepithelioma, Adenoid 
cystic carcinoma, mucoepidermoid carcinoma and 
basal cell adenoma.  
Myoepitheliomas may be considered as a 
variant of pleomorphic adenoma, but lacking the 
typical feature of glandulo ductal differentiation 
(23). Another characteristic feature of 
myothelioma is the absence of chondromyxoid or 
chondroid foci (24). Chondromyxoid foci and 
glanduloductal differentiations are the hallmark 
feature in pleomorphic adenomas. 
Adenoid cystic carcinoma shows epithelial 
and myoepithelial differentiation in three forms: 
Cribriform, Tubular, and Solid (25). However, the 
infiltrative growth pattern and tendency for 
perineural invasion are the salient features of 
adenoid cystic carcinoma.   
The intermediary cells in mucoepidermoid 
carcinoma show similarity to the basal/ 
myoepithelial cells of pleomorphic adenoma. 
Although the intermediary cells have the potential 
to produce the extracellular material, they lack the 
ability to create the myxochondroid stroma. Also, 
squamous differentiation (when present in 
pleomorphic adenoma) is generally well 
developed and may show keratinisation. This 
feature is less evident in carcinoma (26). 
Basal cell adenoma is a subtype of 
pleomorphic adenoma, and was previously termed 
as monomorphic adenoma. The tumor can be 
histologically differentiated from pleomorphic 
adenoma by the absence of chondromyxoid stroma 
and the presence of a uniform basaloid epithelial 
pattern. 
Histopathological features in the current case 
showed salient features of pleomorphic adenoma. 
A well-capsulated cellular mass of sheets and 
islands of epithelial cells and rounded 
myoepithelial cells, along with myxomatous 
background and ductal architecture, was clearly 
evident.  




Aggressiveness and extent of the tumor mass 
and its relation with the facial nerve form the 
important criteria which dictate the choice of 
treatment of pleomorphic adenoma of the parotid 
gland. Enucleation, enucleoresection and 
superficial or total parotidectomy with 
preservation of the facial nerve formed the 
mainstay of surgical treatment (27). 
In the present case, superior lobe of the left 
parotid gland with the tumor mass was excised 
with utmost care to preserve the facial nerve 
branches. Pleomorphic adenomas need to be 
managed diligently as they have a tendency for 
recurrence and malignant transformation. Rupture 
of the capsule and subsequent tumor spillage 
during excision are attributable risk factors for 
recurrence. Up to 10% cases show malignant 
transformation and features predictive of 
malignant change include advancing age, massive 
tumor size, a long duration of the mass, 
occurrence in submandibular salivary gland, and 
hyalinized connective tissue (28). 
The patient in the current case was 
thoroughly followed up for a period of 3 years and 
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